Abstract
The rapid dissemination of carbapenem resistant Enterobacteriaceae (CRE) all over the world represents a matter of concern. This study aims to investigate the prevalence of CRE in clinical isolates recovered from Al Kasr Al-Ainy hospital in the period between August 2015 and February 2017. The isolates were identified by conventional methods and Maldi-TOF spectroscopy. Phenotypic identification of CRE was carried out by Modified Hodge test and genotypic characterization for Extended-Spectrum Beta-Lactamase (ESBL) and CRE genes was also performed. Carbapenemase activity of CRE isolates was confirmed in 46% of the isolates of which, blaNDM-1 and blaOXA-48 were detected in 75%, 59% of the isolates respectively, while blaVIM was detected in 2.3% only. However, blaIMP and blaKPC were not detected in any isolate. All CRE isolates carried at least one ESBL gene, 95.4% of CRE isolates had blaCTX-M-15, 88.6% blaTEM-1, and 68.2% blaSHV. The blaSHV gene showed different alleles in the CRE isolates. All the isolates were sensitive to polymyxin B and colistin while only 36.4% were sensitive to tigecycline. Consequently, microbiologists and clinicians should implement the necessary control measures to prevent the spreading of these resistant bacteria.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have